Origin of the poxviral membrane: A 50-year-old riddle.

by Bernard Moss
Published 2018-06-01

Poxvirus Cell Entry: How Many Proteins Does it Take?

by Bernard Moss
Published 2012-04-01

Lipid Membranes in Poxvirus Replication

by Jason P. Laliberte, Bernard Moss
Published 2010-04-01

The membrane fusion step of vaccinia virus entry is cooperatively mediated by multiple viral proteins and host cell components.

by Jason P Laliberte, Andrea S Weisberg, Bernard Moss
Published 2011-12-01

Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses.

by Patricia L Earl, Jeffrey L Americo, Bernard Moss
Published 2020-04-01

Drosophila S2 cells are non-permissive for vaccinia virus DNA replication following entry via low pH-dependent endocytosis and early transcription.

by Zain Bengali, P S Satheshkumar, Zhilong Yang, Andrea S Weisberg, Nir Paran, Bernard Moss
Published 2011-02-01

Vaccinia Virus Ankyrin-Repeat/F-Box Protein Targets Interferon-Induced IFITs for Proteasomal Degradation

by Ruikang Liu, Lisa R. Olano, Yeva Mirzakhanyan, Paul D. Gershon, Bernard Moss
Published 2019-10-01

Erratum for Sivan et al., “Identification of Restriction Factors by Human Genome-Wide RNA Interference Screening of Viral Host Range Mutants Exemplified by Discovery of SAMD9 and W...

by Gilad Sivan, Pinar Ormanoglu, Eugen C. Buehler, Scott E. Martin, Bernard Moss
Published 2017-10-01

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins

by Linda S. Wyatt, Wei Xiao, Jeffrey L. Americo, Patricia L. Earl, Bernard Moss, Terence S. Dermody
Published 2017-06-01

Zinc-finger antiviral protein (ZAP) is a restriction factor for replication of modified vaccinia virus Ankara (MVA) in human cells.

by Chen Peng, Linda S Wyatt, Shira G Glushakow-Smith, Madhu Lal-Nag, Andrea S Weisberg, Bernard Moss
Published 2020-08-01

SPI-1 is a missing host-range factor required for replication of the attenuated modified vaccinia Ankara (MVA) vaccine vector in human cells.

by Ruikang Liu, Jorge D Mendez-Rios, Chen Peng, Wei Xiao, Andrea S Weisberg, Linda S Wyatt, Bernard Moss
Published 2019-05-01

Induction of Plasmodium falciparum transmission-blocking antibodies by recombinant Pfs25

by David C. Kaslow, Ivan C. Bathurst, Stuart N. Isaacs, David B. Keister, Bernard Moss, Philip J. Barr
Published 1992-01-01

Genome sequence of erythromelalgia-related poxvirus identifies it as an ectromelia virus strain.

by Jorge D Mendez-Rios, Craig A Martens, Daniel P Bruno, Stephen F Porcella, Zhi-Ming Zheng, Bernard Moss
Published 2012-01-01

Poxviruses Encode a Reticulon-Like Protein that Promotes Membrane Curvature

by Karl J. Erlandson, Himani Bisht, Andrea S. Weisberg, Seong-In Hyun, Bryan T. Hansen, Elizabeth R. Fischer, Jenny E. Hinshaw, Bernard Moss
Published 2016-03-01

Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human...

by Sailaja Gangadhara, Young-Man Kwon, Subbiah Jeeva, Fu-Shi Quan, Baozhong Wang, Bernard Moss, Richard W. Compans, Rama Rao Amara, M. Abdul Jabbar, Sang-Moo Kang
Published 2017-12-01

HIV-1 vaccination by needle-free oral injection induces strong mucosal immunity and protects against SHIV challenge

by Andrew T. Jones, Xiaoying Shen, Korey L. Walter, Celia C. LaBranche, Linda S. Wyatt, Georgia D. Tomaras, David C. Montefiori, Bernard Moss, Dan H. Barouch, John D. Clements, Pamela A. Kozlowski, Raghavan Varadarajan, Rama Rao Amara
Published 2019-02-01

Potent functional antibody responses elicited by HIV-I DNA priming and boosting with heterologous HIV-1 recombinant MVA in healthy Tanzanian adults.

by Agricola Joachim, Charlotta Nilsson, Said Aboud, Muhammad Bakari, Eligius F Lyamuya, Merlin L Robb, Mary A Marovich, Patricia Earl, Bernard Moss, Christina Ochsenbauer, Britta Wahren, Fred Mhalu, Eric Sandström, Gunnel Biberfeld, Guido Ferrari, Victoria R Polonis
Published 2015-01-01

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

by Silvia Ratto-Kim, Jeffrey R Currier, Josephine H Cox, Jean-Louis Excler, Anais Valencia-Micolta, Doris Thelian, Vicky Lo, Eddy Sayeed, Victoria R Polonis, Patricia L Earl, Bernard Moss, Merlin L Robb, Nelson L Michael, Jerome H Kim, Mary A Marovich
Published 2012-01-01

Phase I safety and immunogenicity evaluation of MVA-CMDR, a multigenic, recombinant modified vaccinia Ankara-HIV-1 vaccine candidate.

by Jeffrey R Currier, Viseth Ngauy, Mark S de Souza, Silvia Ratto-Kim, Josephine H Cox, Victoria R Polonis, Patricia Earl, Bernard Moss, Sheila Peel, Bonnie Slike, Somchai Sriplienchan, Prasert Thongcharoen, Robert M Paris, Merlin L Robb, Jerome Kim, Nelson L Michael, Mary A Marovich
Published 2010-11-01

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical tri...

by Patricia J Munseri, Arne Kroidl, Charlotta Nilsson, Agricola Joachim, Christof Geldmacher, Philipp Mann, Candida Moshiro, Said Aboud, Eligius Lyamuya, Leonard Maboko, Marco Missanga, Bahati Kaluwa, Sayoki Mfinanga, Lilly Podola, Asli Bauer, Karina Godoy-Ramirez, Mary Marovich, Bernard Moss, Michael Hoelscher, Frances Gotch, Wolfgang Stöhr, Richard Stout, Sheena McCormack, Britta Wahren, Fred Mhalu, Merlin L Robb, Gunnel Biberfeld, Eric Sandström, Muhammad Bakari
Published 2015-01-01